Full Summary
This Wednesday morning, Anthropic is back in the headlines as the US government lifts export controls on its most powerful AI models, Fable 5 and Mythos 5. Both the *Saudi Gazette* and *Business Insider* confirm Anthropic will begin restoring access today, just weeks after a ban was imposed due to national security concerns. The Commerce Department announced Anthropic has addressed the risks that led to the June 12th suspension, agreeing to proactively detect and address security threats and collaborate on future AI releases. However, *trendingtopics.eu* notes that while Fable 5 is now globally available, Mythos 5, with its advanced cybersecurity capabilities, will initially be re-enabled only for certain US organizations. In another major development, Anthropic has launched Claude Science, a new tool automating research workflows for scientists. NAI500 reports this tool can automate tasks in biology and chemistry, including protein structure prediction, and integrates over 60 scientific databases. Following this announcement, shares of several drug discovery-related companies, including Schrodinger Inc. and Recursion Pharmaceuticals Inc., fell sharply, reflecting market concerns about AI's disruptive potential. Meanwhile, tensions are high over Anthropic's stance on China. *The Times of India* and *Gizmodo* report that Anthropic has embedded code in its models to identify and suspend Chinese users, banning accounts suspected of being in China to prevent unauthorized replication of its technology. Anthropic confirmed this was an "experiment" launched in March to prevent account abuse and distillation, and that it should be rolled back with the Fable 5 redeployment. Adding to the industry drama, Palantir CEO Alex Karp is criticizing the token model used by AI labs like Anthropic and OpenAI. Multiple sources, including *CNBC* and *The Tech Buzz*, quote Karp saying something has gone "completely wrong" with rising AI costs, pushing enterprises towards more cost-effective open-weight models. Karp warns that businesses want control over their computing, models, and data, not to transfer it to others. Finally, the Sam Altman biopic "Artificial" has found a new home. Both the *Hindustan Times* and *Mashable SEA* confirm Neon has acquired the film, which stars Andrew Garfield as the OpenAI founder. This comes after Amazon MGM Studios dropped the nearly complete $40 million film, despite Amazon's multi-billion-dollar deal with OpenAI. Neon plans to release it later this year, aiming for the Oscar race. What this means for you: The rapid shifts in AI regulation and corporate strategy directly impact the availability and cost of advanced AI tools. Companies are grappling with how to balance innovation with national security and economic viability, which could influence the features and pricing of AI services you encounter in your daily work or personal life.